Fact CheckerSign in

NCT07176390Active, not recruitingPhase 2

A clinical study of tulisokibart in people with rheumatoid arthritis (MK-7240-014)

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Rheumatoid Arthritis

Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Nov 2026

Brief summary (registry, in English)

To evaluate the efficacy of tulisokibart compared with placebo as assessed by the proportion of participants achieving ACR20 at Week 12.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
56 (estimated)
First submitted
15 Jul 2025
Start date
6 Nov 2025
Lead sponsor
Merck Sharp & Dohme LLC
EU CT number
2025-521745-25-00

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 56
  • 15 sites in 3 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Has any active infection.
  • Has known allergies, hypersensitivity, or intolerance to tulisokibart or its excipients

Age

  • Has any arthritis with onset before age 17 years or current diagnosis of inflammatory joint disease other than RA (such as, but not limited to, psoriatic arthritis, systemic lupus erythematosus, gout, systemic sclerosis, myositis, pseudogout, etc) or any other condition that may, in the judgment of the investigator, interfere with the assessment of RA
  • Has a history of cancer (except fully treated nonmelanoma skin cancers or cervical carcinoma in situ after complete surgical removal) and is disease free for <5 years before randomization

Who the study is looking for

  • Has a clinical diagnosis of rheumatoid arthritis (RA) and fulfillment of 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria
  • Has active disease defined as ≥6 tender joints (based on 68 joints) and ≥6 swollen joints (based on 66 joints)
  • Has current treatment with oral or parenteral methotrexate (MTX) therapy
  • Has history of one of the following: a) biologic disease-modifying antirheumatic drug (bDMARD) naïve, or b) bDMARD-Inadequate Response (IR)/intolerant up to a maximum of 2 classes of bDMARDS

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (15)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rheumatologische Schwerpunktpraxis
Coordinator of this site? Confirm its status
BerlinGermanyActive, not recruiting
Rheuma-Research Lausitz
Coordinator of this site? Confirm its status
CottbusGermanyActive, not recruiting
MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH
Coordinator of this site? Confirm its status
HamburgGermanyActive, not recruiting
Medicover GmbH
Coordinator of this site? Confirm its status
MunichGermanyActive, not recruiting
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainActive, not recruiting
Parc Tauli Hospital Universitari
Coordinator of this site? Confirm its status
SabadellSpainActive, not recruiting
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainActive, not recruiting
Complexo Hospitalario Universitario De Santiago
Coordinator of this site? Confirm its status
Santiago de CompostelaSpainActive, not recruiting
Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy
Coordinator of this site? Confirm its status
BydgoszczPolandActive, not recruiting
Medicover Integrated Clinical Services Sp. z o.o.
Coordinator of this site? Confirm its status
BydgoszczPolandActive, not recruiting
Niepubliczny Zakład Opieki Zdrowotnej Bif-Med S.C.
Coordinator of this site? Confirm its status
BytomPolandActive, not recruiting
Reumed Sp. z o.o.
Coordinator of this site? Confirm its status
LublinPolandActive, not recruiting
Medicover Integrated Clinical Services Sp. z o.o.
Coordinator of this site? Confirm its status
TorunPolandActive, not recruiting
Narodowy Instytut Geriatrii Reumatologii I Rehabilitacji Im Prof. Dr Hab. Med. Eleonory Reicher
Coordinator of this site? Confirm its status
WarsawPolandActive, not recruiting
Medicover Integrated Clinical Services Sp. z o.o.
Coordinator of this site? Confirm its status
WarsawPolandActive, not recruiting

This page is information, not medical advice. Discuss any trial with your doctor.